Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 30.6B | 32.7B | 32.5B | 32.6B |
Cost of revenue | 20.5B | 21.9B | 21.9B | 22.5B |
Gross profit | 10.1B | 10.8B | 10.6B | 10.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 4.7B | 4.7B | 4.2B | 3.8B |
Operating income | 2.0B | 2.7B | 3.1B | 3.1B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 100M | 112.5M | 136.1M | 94.4M |
Other income expense | — | — | — | — |
Pretax income | 2.1B | 4.1B | 3.2B | 3.3B |
Tax provision | 510.5M | 1.1B | 814.6M | 855.9M |
Net income | 1.6B | 3.0B | 2.4B | 2.5B |
Basic EPS | — | 16.3 | 12.9 | 13.6 |
Diluted EPS | — | 16.3 | 12.9 | 13.6 |
Basic average shares | — | 183.0M | 183.1M | 183.0M |
Diluted average shares | — | 183.0M | 183.1M | 183.0M |
EBITDA | 3.7B | 4.4B | 4.6B | 4.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |